ERBB2 and breast cancer: These pivotal studies found that breast cancers with triple-negative characteristics do not always overlap with the basal-like subtype, which means that although approximately 90% of TNBC cases are basal-like breast cancer (BLBC) [8], the rest of TNBC cases show the other breast cancer subtypes, such as HER2 enriched or luminal B subtypes.